about
Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease.Cardiologic side effects of psychotropic drugs.Sleep modifications in acute transient global amnesia.Neural correlate of Internet use in patients undergoing psychological treatment for Internet addiction.Psychiatric emergencies and services availability: a comparison of two hospitals in Rome.Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.Duloxetine for premenstrual dysphoric disorder: a pilot study.Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.[Temperament and attachment in alcohol addicted patients of type 1 and 2].Further evidence supporting the association between 5HTR2C gene and bipolar disorder.Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain.Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction.Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients.Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA.Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature?What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients.Left thalamomegaly in a patient with partial epilepsy.Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment.Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance.Is Internet addiction a psychopathological condition distinct from pathological gambling?Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications.To be or not to be a bipolar disorder patient: problems with diagnosis.Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up.Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state.Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome.A Mixed Program of Psychoeducational and Psychological Rehabilitation for Patients With Bipolar Disorder in a Day Hospital Setting.A treatment protocol for suicidal patients in a day hospital setting: preliminary results.Day hospital treatment for mood disorders.Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS).Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-QDrugs for attention deficit–hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studiesOxcarbazepine at High Dosages for the Treatment of Alcohol Dependence[Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder]Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study][An observational study evaluating comorbidity between bipolar disorder and personality disorders]An update on pharmacotherapy for personality disorders
P50
Q34887731-D51088BD-6958-436F-9729-543F0A47489FQ36077336-8B3367BD-8BF5-4763-8217-3463BFB4B0D3Q37103437-97D36132-88BF-4CBB-A788-374C83A79ADEQ38731901-1412AA29-86A7-4CE9-A0FF-385EA7D94C80Q39693653-706FE516-96A3-4C8F-B871-4B04656EA153Q40031449-AA90213F-5175-4EAE-87A1-EE6104ACA9E3Q42646970-6035534B-BB81-41BA-B0D6-2C7813F97D0FQ42655671-E5A4C913-1197-4938-9682-6575A917AB55Q42754802-62E6F9A3-A742-4DD0-A019-57D31AA004BBQ43056452-3A0C105C-CFB2-4DF7-9369-1E6C43A3B327Q43093983-894050DE-8976-47E4-8FF4-8CD92AB77FE6Q43125059-AFDAD77A-69FB-474C-81D8-6018A53ED459Q43441394-0CAC1759-9144-4B11-BFA9-AD3EAA39584DQ43862162-AFC14114-34B3-4026-876D-F57C1E668342Q44636877-112D7DD6-17C0-4347-B585-87BA37312965Q45900080-AAF46680-AC89-46C5-8948-125D881D37F5Q46046782-259780DB-01CB-4312-85A6-03741B5A8B22Q46061241-7C0C7468-8048-4ED4-A896-AD40DF7CA842Q46068783-594FAD6E-6EE2-46B4-AF11-132206FB4819Q46838777-96729CAE-EF8D-4E2D-9A0B-EF1A772FF98BQ48080807-C3263A81-9A10-4933-A2A1-9E18DF27FAD6Q48315286-98D8C4FB-61CD-4126-A2FA-EEE3846A891DQ48334349-0600303E-A096-4E5C-90E9-DB00E11A9827Q48420522-B054F8D5-1841-44C0-A815-CCF3AF7598F7Q48479065-24C47DEF-4B3A-42C8-AF1E-86A0C1A54EF9Q48489225-D0BE72F4-D16B-458E-A3C0-C69A6B8066A2Q48635782-4AC90AC1-96B3-4324-BCCC-7E36EECAD361Q48717255-09E73A53-A38D-4134-B290-46235479E4FFQ50118019-09F81258-E5F2-4946-A3FB-553A4071C10CQ51938425-DA883C26-6D49-4757-B88A-FEEFAC2A4B30Q51941874-62917CFF-6AD0-42DF-BB60-90743F8C55A4Q55513871-86C5F26D-5532-4FAA-B69A-F23E28050C6DQ57117265-8326ED84-CEAF-4670-A0D3-C1998218CD81Q57730858-5EC803B4-C6E6-4833-9316-278884CADB83Q58170748-466369C1-AB12-44F2-A28F-223A1A8564ABQ61633358-F48AC33C-F9D9-4DE7-BF93-9CC31E6A55F0Q82758230-7E438287-B4D6-4CB6-86AC-8E970C243B0EQ84009268-06E490EF-8D2C-4982-9255-2C0C614CB11AQ84066932-8E4430EC-86AC-4605-A21F-0254EF45F503Q88052176-62AE9F8D-BF9E-42D0-9560-783A3AA25B73
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marianna Mazza
@ast
Marianna Mazza
@en
Marianna Mazza
@es
Marianna Mazza
@nl
type
label
Marianna Mazza
@ast
Marianna Mazza
@en
Marianna Mazza
@es
Marianna Mazza
@nl
prefLabel
Marianna Mazza
@ast
Marianna Mazza
@en
Marianna Mazza
@es
Marianna Mazza
@nl
P106
P1153
7006184722
P21
P31
P496
0000-0002-3007-8162